Urology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Urology Devices Market is segmented by Product (Instruments, consumables, and Accessories), Diseases (Kidney Diseases, Urological Cancer and BPH, Pelvic Organ Prolapse, Other Diseases), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers the value (USD million) for the above segments.

Market Snapshot

Urology Devices Market Summary
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.35 %
Urology Devices Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global urology devices market is growing at a rate of 6.35% during the forecast period (2022-2027).

The global spread of COVID-19 has flooded many healthcare institutions with severely ill patients and medical equipment such as dialysis machines, endoscopes, and lithotripsy machines. COVID-19 causes acute respiratory distress and acute renal damage in individuals. Multi-organ failure and renal failure can occur when the patient's body cannot remove excess waste and fluids from the body. As a result of the use of dialysis equipment in the treatment of patients, the urology device market has a beneficial impact on COVID-19. However, urology practices have decreased during the pandemic. Thus, COVID-19 has a mixed impact on the market studied.

The key factors propelling the market growth include a high incidence of urologic conditions, a rising senior population, and technological advancements.

According to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIs), and kidney and ureteral stones are among the most common urological diseases. The United States According to the National Institute of Medicine July 2020, urinary tract infection affects approximately 150 million people globally. In addition, about 11% of women visit one physician yearly for urinary tract infection treatment. Urinary tract infections (UTIs) are among the most common microbial diseases affecting people of all ages. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs. With a global increase in the diabetic population, complications like dysuria and organ damage are associated with UTIs, which are also rising.

Additionally, according to the article published in the International Journal of Molecular medicine in August 2020, Kidney stone disease, also known as nephrolithiasis or urolithiasis, is one of medicine's oldest diseases. It is estimated that 11% of people will develop kidney stones at some point in their lives, and the prevalence and incidence of kidney stones are increasing worldwide. However,  the overall prevalence of urolithiasis was 11.2 %, with 48.8 % having a first-degree relative with the disease. Males were 1.8 times more likely than females to have urolithiasis.

Hence, with the high incidence rates and health complications associated with urological diseases, there is an increasing demand for healthcare interventions to manage them, which, in turn, is propelling the market of urology devices market.

Scope of the Report

As per the scope of the report, urological conditions include kidney stone disease (urolithiasis), incontinence in men and women, benign prostate hyperplasia (BPH), and noncancerous prostate swelling in men with increasing age, prostate cancer, and erectile dysfunction in men. Therefore, urologists utilize these devices for the treatment of urinary disorders. The Urology Devices Market is segmented by Product, Disease (Instruments, consumables, and Accessories), By Diseases (Kidney Diseases, Urological Cancer and BPH, Pelvic Organ Prolapse, Other Diseases), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers the value (USD million) for the above segments.

By Product
Dialysis Devices
Endoscopes and Endovision Systems
Lasers and Lithotripsy Devices
Other Instruments
By Consumables and Accessories
Dialysis Consumables
Guidewires and Catheters
Biopsy Devices
Other Consumables and Accessories
By Disease
Kidney Diseases
Urological Cancer and BPH
Pelvic Organ Prolapse
Other Diseases
By End User
Hospitals and Clinics
Dialysis Centers
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Kidney Disease Segment Expected to Hold the Highest Market Share

The various kidney diseases include renal cyst, cystic kidney diseases, chronic kidney disease, hemolytic-uremic syndrome, and lupus nephrite, among others. Most kidney diseases lead to kidney failure, which requires early diagnosis for prompt treatment.

According to the article published in the National Institutes of Health in September 2021 by Onecia Benjamin and Sarah L. Lappin., End-stage renal disease (ESRD) affects more than 500,000 persons in the United States annually. The prevalence of CKD rises with age, with persons aged 60 and up experiencing the fastest development. The frequency is 6.0 % among those aged 18 to 44 and 38.1% among those aged 65 and up.

National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK) in 2020, ESKD, also known as an end-stage renal disease (ESRD), affects almost 786,000 people in the United States with 71% requiring dialysis and 29% requiring a kidney transplant. ESKD affects three men and every two women who develop it. However, most of the population remains undiagnosed in the early stages, eventually leading to death worldwide.

Therefore, an increase in awareness, along with support from the government through reimbursement and innovation in products to develop a low-cost and effective treatment, are some elements expected to drive the market over the forecast period.

Urology Devices Market - Standardized Infection Ratio for Catheter-Associated Urinary Tract Infections, by State, 2020

North America is Dominating the Market and is Expected to do the Same During the Forecast Period

North America currently dominates the market for urology devices, and it is expected to continue its stronghold for a few more years. Benign prostatic hyperplasia (BPH) is among the most untapped segments in the urology market. Several United States-based companies are working on upgrading their devices in this segment, either by collaboration or acquisition.

The region is experiencing a drastic increase in innovations related to diagnostic methodologies used for UTIs. According to the article published in Infectious Diseases Society of America in November 2020, by Pranita D. Tamma, during a routine checkup for a UTI, a woman was observed to be infected by E. coli that showed resistance to the last-resort antibiotic, Colistin. The discovery of Colistin-resistant bacteria was considered a major issue. In addition to that, the CDC, in collaboration with other organizations, developed guidelines for preventing catheter-associated UTIs and other healthcare-associated infections in the United States. UTIs are a substantial societal and personal burden, accounting for many medical visits in the United States each year. This condition drives the market by increasing sales of urology devices.

Thus, over the forecast period, technological advancements, a high percentage of urology cases in hospitals, and increasing funding are expected to be the major drivers for the growth of the urology devices market.

Urology Devices Market- Growth Rate by Region

Competitive Landscape

The urology devices market is highly competitive and consists of several major players. With increasing technological advancements and product innovations, mid-size to smaller companies are expected to increase their market presence by introducing new devices at lesser prices. These companies, like Baxter, Boston Scientific, C. R. Bard, Medtronic, and Siemens, hold a substantial share in the market.

Recent Development

  • In September 2021, LiNA Medical partnered with UroCure to develop a range of surgical solutions for female stress urinary incontinence.
  • In January 2021, Advanced Medtech led Devicare's USD 3 million series A fundraising event to bring digitalized management medical devices and urological medical to market. Devicare's strategic investment adds to Advanced MedTech's product portfolio and improves its position as a leader in urology and kidney stone management.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Incidence of Urologic Conditions

      2. 4.2.2 Rising Geriatric Population

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Policies for Validation of Medical Devices

      2. 4.3.2 High Cost of Urology Devices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Product

      1. 5.1.1 Instruments

        1. Dialysis Devices

        2. Endoscopes and Endovision Systems

        3. Lasers and Lithotripsy Devices

        4. Other Instruments

      2. 5.1.2 By Consumables and Accessories

        1. Dialysis Consumables

        2. Guidewires and Catheters

        3. Stents

        4. Biopsy Devices

        5. Other Consumables and Accessories

    2. 5.2 By Disease

      1. 5.2.1 Kidney Diseases

      2. 5.2.2 Urological Cancer and BPH

      3. 5.2.3 Pelvic Organ Prolapse

      4. 5.2.4 Other Diseases

    3. 5.3 By End User

      1. 5.3.1 Hospitals and Clinics

      2. 5.3.2 Dialysis Centers

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Baxter International Inc.

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 Cook Medical Incorporated

      5. 6.1.5 Stryker Corporation

      6. 6.1.6 Fresenius Medical Care AG & Co. KGaA

      7. 6.1.7 Intuitive Surgical Inc.

      8. 6.1.8 Karl Storz SE & Co. KG

      9. 6.1.9 Medtronic PLC

      10. 6.1.10 Olympus Corporation

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Urology Devices Market market is studied from 2019 - 2027.

The Global Urology Devices Market is growing at a CAGR of 6.35% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Baxter International Inc., Boston Scientific Corporation, Becton, Dickinson and Company, Medtronic PLC, Siemens Healthineers are the major companies operating in Global Urology Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!